重大胰腺损伤行左侧胰腺切除时脾切除与否的结局比较
基于2018-2021年TQIP数据库,纳入758例≥16岁胰腺损伤行左侧胰腺切除且排除合并脾损伤的患者,比较脾切除与保脾的围术期结局。风险调整后,脾切除与院内死亡率(aOR 0.81,95%CI 0.47-1.38)及主要不良事件(aOR 0.97,95%CI 0.68-1.39)无显著关联,支持个体化决策。
要点
- 重大胰腺损伤左侧胰腺切除中,脾切除与保脾的院内死亡率和主要并发症无显著差异。
- 脾切除组损伤严重度评分更低且手术时间更短,提示选择偏倚需风险调整。
- 研究期间脾切除使用率保持稳定,支持个体化手术决策。
核心结论
- 左侧胰腺切除联合脾切除与保脾相比,术后死亡率和主要并发症无显著差异。
研究设计与样本
- 回顾性队列研究,查询2018-2021年创伤质量改进计划(TQIP)数据库。
- 纳入≥16岁胰腺损伤行左侧胰腺切除患者,排除合并脾损伤,共758例。
- 按是否行脾切除分为脾切除组393例(51.8%)和保脾组365例(48.2%)。
- 采用多变量回归模型评估脾切除与结局的独立关联。
主要发现
- 脾切除组损伤严重度评分更低(0.05 vs 0.07;P < .001),手术时间更短(64 vs 519分钟;P < .001)。
- 风险调整后,脾切除与院内死亡率无显著关联(aOR 0.81;95%CI 0.47-1.38)。
- 风险调整后,脾切除与主要不良事件无显著关联(aOR 0.97;95%CI 0.68-1.39)。
- 心脏、呼吸、血栓栓塞、感染和肾脏并发症发生率及ICU入住率和住院时间两组相当。
- 研究期间脾切除使用率保持稳定(nptrend 0.18)。
临床怎么用
- 对于无合并脾损伤的胰腺损伤行左侧胰腺切除,脾切除与否应基于个体化判断。
- 保脾策略不增加院内死亡或主要并发症风险,可考虑用于合适患者。
局限性
- 长期脓毒症并发症和随访情况有待进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Traumatic pancreatic injuries carry significant mortality and often involve splenectomy because of the anatomic proximity of the spleen. However, current trauma guidelines provide no evidence-based recommendation for or against routine splenectomy at the time of left-sided pancreatectomy, instead advocating an individualized approach. Contemporary data comparing left-sided pancreatectomy management with splenectomy and without splenectomy (nonsplenectomy) remain limited. We evaluated perioperative outcomes following splenectomy versus nonsplenectomy left-sided pancreatectomy in a national trauma cohort. METHODS: The 2018-2021 Trauma Quality Improvement Program was queried for patients ≥16 years with pancreatic injury undergoing left-sided pancreatectomy. Those with concomitant splenic injury were excluded, and records were stratified by whether splenectomy was performed. The primary end point was in-hospital mortality. Secondary outcomes included major adverse events, individual complications, intensive care unit admission, and intensive care unit length of stay. Multivariable regression models assessed the independent association between splenectomy and left-sided pancreatectomy and outcomes. RESULTS: Of 758 patients, 393 (51.8%) underwent splenectomy, and 365 (48.2%) underwent nonsplenectomy. Splenectomy patients had lower Traumatic Injury Machine Learning-based scores (0.05 vs 0.07; P < .001) and shorter time to operation (64 vs 519 minutes; P < .001). Following risk adjustment, splenectomy was not associated with differences in in-hospital mortality (adjusted odds ratio, 0.81; 95% confidence interval, 0.47-1.38) or major adverse events (adjusted odds ratio, 0.97; 95% confidence interval, 0.68-1.39). Rates of cardiac, respiratory, thromboembolic, infectious, and renal complications were comparable between cohorts, as were intensive care unit admission and length of stay. Utilization remained stable throughout the study period (nptrend, 0.18). CONCLUSION: Left-sided pancreatectomy with splenectomy was not associated with differences in postoperative mortality or major complications compared with nonsplenectomy left-sided pancreatectomy. These findings support individualized operative decision-making, whereas long-term septic complications and follow-up warrant further investigation.
引用
- Tabibian D, Tabibian K, Chaturvedi A, et al. Outcomes following left-sided pancreatectomy management with and without splenectomy for major pancreatic injury. Surgery. 2026. PMID: 42822387. doi:10.1016/j.surg.2026.110651
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。